The IMA Group Acquires Amici Clinical Research
March 2, 2022
The IMA Group's Clinical Research division acquired Amici Clinical Research, adding two New Jersey clinical trial sites (Raritan and Hoboken) to IMA's network. The acquisition expands IMA's Northeast footprint and therapeutic capabilities across areas including fatty liver, cardiovascular, pulmonary and neurologic diseases, and supports site-based, hybrid and decentralized trials.
- Buyers
- The IMA Group (IMA Clinical Research)
- Targets
- Amici Clinical Research
- Platforms
- IMA Clinical Research
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
The IMA Group Acquires Clinical Trials of America
January 11, 2023
Healthcare Services
The IMA Group’s clinical research division, IMA Clinical Research, has acquired Clinical Trials of America (CTA), adding 10 site locations (four independent and six embedded) and expanding IMA’s reach in Louisiana and North Carolina. CTA will continue to operate under existing leadership, and the deal increases IMA’s clinical network and therapeutic capabilities to better serve sponsors and CROs; terms were not disclosed.
-
The IMA Group Acquires Accelemed Research Institute
April 11, 2023
Healthcare Services
The IMA Group (IMA Clinical Research) has acquired Accelemed Research Institute, a clinical research site in Austin, Texas, expanding IMA's footprint in the Southwest to more than 20 sites. The acquisition deepens IMA's capabilities in multi-therapeutic clinical trials—particularly cardiometabolic and GI indications—and keeps Accelemed operating under its current name with existing leadership retained.
-
The IMA Group Acquires Exemplar Research, Inc.
November 30, 2021
Healthcare Services
The IMA Group (IMA Clinical Research) has acquired Exemplar Research, Inc., a community-based specialty research clinic serving the North Central region of West Virginia. The acquisition expands IMA's clinical trial network and broadens access to diverse patient populations and therapeutic capabilities in underserved areas.
-
The IMA Group Acquires Albuquerque Neuroscience, Inc.
September 9, 2021
Healthcare Services
The IMA Group has acquired Albuquerque Neuroscience, Inc., a clinical research site specializing in central nervous system (CNS) and general medical condition trials. The acquisition expands IMA Clinical Research's national footprint and deepens its capabilities in psychiatry, Alzheimer's disease and other neuropathic therapeutic areas; financial terms were not disclosed.
-
The IMA Group Acquires Chicago Research Center
October 8, 2025
Healthcare Services
The IMA Group (IMA Clinical Research), a PE-backed national clinical research platform, has acquired Chicago Research Center (CRC), an independent clinical research site in Chicago specializing in CNS and sleep disorder trials. The deal expands IMA's geographic footprint and capabilities—marking its first dedicated sleep research site—and will keep CRC's leadership and staff in place to support Phase I–IV trials.
-
The IMA Group Acquires Medical Research Network (MRN) LLC
July 22, 2025
Healthcare Services
The IMA Group has acquired Medical Research Network (MRN) LLC, a New York City–based clinical research site specializing in psychiatry and neurology (CNS) trials. MRN will continue to operate under its current name and leadership (founder and CEO Dr. Michael R. Liebowitz), and the deal expands IMA's CNS footprint with its first East Coast CNS-dedicated location.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.